Gerald Scott Barden Horan

Title: Gerald Scott Barden Horan: Innovator in Pharmaceutical Measurement Techniques

Introduction

Gerald Scott Barden Horan is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of pharmaceutical measurement techniques, holding 2 patents that focus on innovative methods for evaluating drug effects.

Latest Patents

Horan's latest patents include methods for the measurement of inhibition of c-Jun N-terminal kinase in skin. These methods evaluate the effect of a specific compound, 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, in patients. The assays are based on UVB-irradiation and phosphorylated c-Jun expression, allowing for dose-response evaluations and the identification of patient populations sensitive to the compound.

Career Highlights

Gerald Horan is currently associated with Signal Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in enhancing the understanding of drug interactions and patient responses.

Collaborations

Horan collaborates with Ying Ye, contributing to the innovative research environment at Signal Pharmaceuticals, Inc. Their combined expertise fosters advancements in pharmaceutical methodologies.

Conclusion

Gerald Scott Barden Horan is a distinguished inventor whose work in pharmaceutical measurement techniques has the potential to significantly impact patient care and drug efficacy. His contributions are vital to the ongoing evolution of medical research and innovation.